This activity is designed to help clinicians better understand the latest thinking on anti-obesity medications and how best to optimize care for those using those medications. This activity is part of the Anti-Obesity Medications: Practical Approaches to Improve Weight Health grant project.
Accreditation Statement
In accordance with ACCME policy, prior to participating in this activity, you must review the information on this page.
Joint Accreditation In support of improving patient care, the American College of Cardiology Foundation (ACCF) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement
Physicians
The ACCF designates this online enduring material for a maximum of up to .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience:
The target audience for this education is CV team clinicians including physicians, nurse practitioners, physician assistants, and pharmacists who manage patients who need cardiovascular care with weight-related comorbidities.
Important Dates: Date of Release: June 4, 2023Term of Approval/Date of Expiration: June 4, 2024 Learner Objectives: Upon completion of this activity, you should be able to:
Acknowledgements: Educational grant support provided by: Novo Nordisk.
Faculty:
Sheldon Litwin, MD, FACC Peer Reviewer: Pamela Bowe Morris, MD, FACC